Copyright Reports & Markets. All rights reserved.

Global Branded Generics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Branded Generics Industry
  • 1.7 COVID-19 Impact: Branded Generics Market Trends

    • 2 Global Branded Generics Quarterly Market Size Analysis

    • 2.1 Branded Generics Business Impact Assessment - COVID-19
      • 2.1.1 Global Branded Generics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Branded Generics Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Branded Generics Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Branded Generics Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Branded Generics Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Branded Generics Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Branded Generics Market
    • 3.5 Key Manufacturers Branded Generics Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Branded Generics Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Oral
      • 1.4.2 Parenteral
      • 1.4.3 Topical
      • 1.4.4 Other
    • 4.2 By Type, Global Branded Generics Market Size, 2019-2021
      • 4.2.1 By Type, Global Branded Generics Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Branded Generics Price, 2020-2021

    5 Impact of Covid-19 on Branded Generics Segments, By Application

    • 5.1 Overview
      • 5.5.1 Oncology
      • 5.5.2 Cardiovascular Diseases
      • 5.5.3 Diabetes
      • 5.5.4 Neurology
      • 5.5.5 Gastrointestinal Diseases
    • 5.2 By Application, Global Branded Generics Market Size, 2019-2021
      • 5.2.1 By Application, Global Branded Generics Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Branded Generics Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Mylan NV
      • 7.1.1 Mylan NV Business Overview
      • 7.1.2 Mylan NV Branded Generics Quarterly Production and Revenue, 2020
      • 7.1.3 Mylan NV Branded Generics Product Introduction
      • 7.1.4 Mylan NV Response to COVID-19 and Related Developments
    • 7.2 Novartis AG
      • 7.2.1 Novartis AG Business Overview
      • 7.2.2 Novartis AG Branded Generics Quarterly Production and Revenue, 2020
      • 7.2.3 Novartis AG Branded Generics Product Introduction
      • 7.2.4 Novartis AG Response to COVID-19 and Related Developments
    • 7.3 Eva Pharmaceutical Industries
      • 7.3.1 Eva Pharmaceutical Industries Business Overview
      • 7.3.2 Eva Pharmaceutical Industries Branded Generics Quarterly Production and Revenue, 2020
      • 7.3.3 Eva Pharmaceutical Industries Branded Generics Product Introduction
      • 7.3.4 Eva Pharmaceutical Industries Response to COVID-19 and Related Developments
    • 7.4 Pfizer
      • 7.4.1 Pfizer Business Overview
      • 7.4.2 Pfizer Branded Generics Quarterly Production and Revenue, 2020
      • 7.4.3 Pfizer Branded Generics Product Introduction
      • 7.4.4 Pfizer Response to COVID-19 and Related Developments
    • 7.5 Sun Pharmaceutical Industries
      • 7.5.1 Sun Pharmaceutical Industries Business Overview
      • 7.5.2 Sun Pharmaceutical Industries Branded Generics Quarterly Production and Revenue, 2020
      • 7.5.3 Sun Pharmaceutical Industries Branded Generics Product Introduction
      • 7.5.4 Sun Pharmaceutical Industries Response to COVID-19 and Related Developments
    • 7.6 Aspen Pharmacare Holding
      • 7.6.1 Aspen Pharmacare Holding Business Overview
      • 7.6.2 Aspen Pharmacare Holding Branded Generics Quarterly Production and Revenue, 2020
      • 7.6.3 Aspen Pharmacare Holding Branded Generics Product Introduction
      • 7.6.4 Aspen Pharmacare Holding Response to COVID-19 and Related Developments
    • 7.7 Abbott Laboratories
      • 7.7.1 Abbott Laboratories Business Overview
      • 7.7.2 Abbott Laboratories Branded Generics Quarterly Production and Revenue, 2020
      • 7.7.3 Abbott Laboratories Branded Generics Product Introduction
      • 7.7.4 Abbott Laboratories Response to COVID-19 and Related Developments
    • 7.8 Bausch Health
      • 7.8.1 Bausch Health Business Overview
      • 7.8.2 Bausch Health Branded Generics Quarterly Production and Revenue, 2020
      • 7.8.3 Bausch Health Branded Generics Product Introduction
      • 7.8.4 Bausch Health Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Branded Generics Supply Chain Analysis
      • 8.1.1 Branded Generics Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Branded Generics Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Branded Generics Distribution Channels
      • 8.2.2 Covid-19 Impact on Branded Generics Distribution Channels
      • 8.2.3 Branded Generics Distributors
    • 8.3 Branded Generics Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Branded Generics, including the following market information:
      Global Branded Generics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Branded Generics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Branded Generics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Branded Generics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

      Key market players
      Major competitors identified in this market include Mylan NV, Novartis AG, Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories, Bausch Health, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Oral
      Parenteral
      Topical
      Other

      Based on the Application:
      Oncology
      Cardiovascular Diseases
      Diabetes
      Neurology
      Gastrointestinal Diseases

      Buy now